Latest videos


Week 7 session 2 for Urology Collaborative Online Virtual Didactics (COViD) lecture series.
Date: 5.11.2020
Topic: Epidemiology, Genetics, and Staging of RCC
Speaker: Gopal Gupta, MD, FACS
Moderator: Parth Patel, MD
learn more: https://urologycovid.ucsf.edu/


RELATED CONTENT
➡️ Cervical Cancer Signs -- https://youtu.be/C-yYg1T-ap0
➡️ Pediatric Rare Hepatitis: https://youtu.be/NYu0tzeZrF8
➡️ ALL About Monkeypox: https://youtu.be/gSWeQl0uKBI
➡️ Bioprinting & its Future in Medicine! https://youtu.be/GZqGoU3myQM
SUPPORT THE CHANNEL
➡️ Subscribe: https://tinyurl.com/medxclusiveSUB
➡️ Blog: https://medXclusive.org
➡️ Subscribe to us for Medicine, Preventive Medicine, Board Exams' High Yield Review + QBank, Health Tips, & Patient Awareness.
➡️ Check out our playlists:
USMLE High Yield Qbank: https://youtu.be/RtCBukwxPMw
Medical High Yield Review: https://youtu.be/GRulrRJdTJ4
Medical Up-to-Date: https://youtu.be/ZuU6LpsSkiA
Medical Animation: https://youtu.be/EeE7Fpg061I
Medical Topics: https://youtu.be/jpTeSWML9ks
Preventative Medicine: https://youtu.be/CaaoU0tsTFQ
For Complete list of Playlists, Visit: https://www.youtube.com/medxclusivelearnings
CREDITS
➡️ Music: https://www.youtube.com/channe....l/UCroT3lzmdQUabW1WA
—————————————————————————————————————-
—————————————————————————————————————- -
This channel is directed towards healthcare professionals, students, & individuals with a genuine interest in medical education. As members of the medical community, it is imperative to remember that healthcare is centered around care & compassion. Our objective is to offer accessible & up-to-date medical information through written materials (blog) & multimedia content. Our hope is that this platform serves as a useful resource for exam preparation & staying current with medical news - for free.
Subscribe for Medical News, Preventive Medicine, Board Exam Review + Qbank, Health Tips & Patient awareness videos. Hope you support us in our journey!
*Disclaimer: The information provided on this channel is for educational purposes only & is not intended as medical advice or diagnosis. Please consult a licensed healthcare provider for personal medical advice & treatment.*
Any Video Clips Used - are used with permission or under fair use: Section 105 of the Copyright Act (17 U.S.C. § 105)


2020-2021 AY: Week 29 for Urology Collaborative Online Virtual Didactics (COViD)
Date: 5.24.2021
Topic: Genetic Basis of Kidney Cancer
Speaker: W. Marston Linehan, MD
Evaluation link: https://redcap.ucsf.edu/survey....s/index.php?s=JANJEF
learn more: https://urologycovid.ucsf.edu/


Description of pathologic typing and grading of RCC, on microscopic examination.
Video source: Pathweb
Register for FREE access to Pathweb: https://nus.syd1.qualtrics.com..../jfe/form/SV_aeYDYT8
Pathweb online resource: https://medicine.nus.edu.sg/pathweb/
Pathweb instagram: https://www.instagram.com/pathweb/


Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer (2021)
CME Available: https://auau.auanet.org/node/31465
ACKNOWLEDGEMENTS
Support provided by independent educational grants from AstraZeneca, Bristol Myers Squibb and Merck.
At the conclusion of the activity, participants will be able to:
1. Differentiate among the subtypes of kidney cancer, with emphasis on clinical management decisions and outline ways in which knowledge of kidney cancer subtypes can alter surgical approach.
2. Apply advanced strategies for partial nephrectomy for patients with endophytic, hilar and multiple tumors including role of warm ischemia, intraoperative ultrasound, techniques for hemostatic control, the role of off-clamp and selective hilar clamping, the use of the retroperitoneal approach, and methods for renorrhaphy.
3. Employ techniques for management of large and/or locally advanced tumors including management of renal vein or inferior vena cava invasion and the use of lymphadenectomy.
4. Identify the role of cytoreductive nephrectomy and/or resection of metastatic foci in patients with advanced disease.
5. Describe new and emerging targeted therapy and immuno-oncology options for patients with locally-advanced and advanced kidney cancer and the role of adjuvant therapy.